[{"Assets_0_FY_USD":347315000.0,"CommonStockSharesOutstanding_0_FY_shares":45224480.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-61257000.0,"NetIncomeLoss_1_FY_USD":-19066000.0,"NetIncomeLoss_4_FY_USD":-85343000.0,"StockholdersEquity_0_FY_USD":277920000.0,"Ticker":"NTLA","CIK":"1652130","name":"INTELLIA THERAPEUTICS, INC.","OfficialName":"Intellia Therapeutics Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4259315236.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20190227"}]